A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA).
- DOI
- 10.1080/17460441.2026.2716137
- Published
- 2026 Sep
- Container
- Expert opinion on drug discovery
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17460441.2026.2716137,
title = {A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA).},
author = {De Jesús-González LA and Santos-Mena AO and Farfán-Morales CN and León-Juárez M and Reyes-Ruiz JM and Osuna-Ramos JF and Cordero-Rivera CD and Palacios-Rápalo SN and Lira-Hernández FI and Del Ángel RM},
year = {2026},
journal = {Expert opinion on drug discovery},
doi = {10.1080/17460441.2026.2716137},
url = {https://doi.org/10.1080/17460441.2026.2716137}
}RIS
TY - JOUR TI - A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA). AU - De Jesús-González LA AU - Santos-Mena AO AU - Farfán-Morales CN AU - León-Juárez M AU - Reyes-Ruiz JM AU - Osuna-Ramos JF AU - Cordero-Rivera CD AU - Palacios-Rápalo SN AU - Lira-Hernández FI AU - Del Ángel RM PY - 2026 JO - Expert opinion on drug discovery DO - 10.1080/17460441.2026.2716137 UR - https://doi.org/10.1080/17460441.2026.2716137 ER -
APA
LA, D. J., AO, S., CN, F., M, L., JM, R., JF, O., CD, C., SN, P., FI, L., & RM, D. Á. (2026). A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA).. Expert opinion on drug discovery. https://doi.org/10.1080/17460441.2026.2716137
Source records
- pubmed · retrieved 2026-09-26T14:13:56.220Z